{"id":"W2944052075","doi":"10.1186/s13223-019-0337-2","title":"Omalizumab in patients with severe asthma and persistent sputum eosinophilia","year":2019,"lang":"en","type":"article","venue":"Allergy Asthma and Clinical Immunology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Institut universitaire de cardiologie et de pneumologie de Québec; St. Joseph’s Healthcare Hamilton; University of British Columbia; McMaster University; Université Laval; Université de Montréal; McGill University; University of Calgary","funders":"Novartis Pharmaceuticals Canada; Université de Montréal; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; AllerGen; Canadian Allergy, Asthma and Immunology Foundation","keywords":"Omalizumab; Medicine; Eosinophilia; Asthma; Sputum; Placebo; Immunoglobulin E; Randomized controlled trial; Internal medicine; Corticosteroid; Intensive care medicine; Immunology; Pediatrics; Antibody; Pathology; Alternative medicine; Tuberculosis","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007499412,0.0002575394,0.001394954,0.0002048318,0.0003153921,0.0003819001,0.0001551435,0.0006024216,0.002570081],"category_scores_gemma":[0.001253363,0.0001093682,0.0006588462,0.0004288165,0.0001995822,0.0003035638,0.0002097995,0.0006860089,0.0002981122],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002558076,"about_ca_system_score_gemma":0.000372447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005589079,"about_ca_topic_score_gemma":0.001201886,"domain_scores_codex":[0.9995981,0.0002016576,0.00004379097,0.00004806233,0.00003989872,0.00006854298],"domain_scores_gemma":[0.9994398,0.000210565,0.0001445435,0.00002354451,0.00003171011,0.0001498471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3477024,0.003838169,0.2854268,0.006959757,0.003102142,0.005262023,0.0003551928,0.0004762684,0.01444731,0.0008190345,0.01713805,0.3144729],"study_design_scores_gemma":[0.1106311,0.07017196,0.7645719,0.002169334,0.003699305,0.009732308,0.000582639,0.001689116,0.00227671,0.00179255,0.03260123,0.00008181423],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9057634,0.08021374,0.0004309335,0.003282398,0.0006469226,0.0006153468,0.0006042788,0.00004191337,0.008401093],"genre_scores_gemma":[0.9919981,0.005035661,0.0003398411,0.001169154,0.0003332241,0.0001568799,0.0003793974,0.000002832185,0.0005848489],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002570081,"threshold_uncertainty_score":0.008597791,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007977085161605273,"score_gpt":0.2515715056945071,"score_spread":0.2435944205329019,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}